Your browser is no longer supported. Please, upgrade your browser.
Settings
ELGX Endologix, Inc. daily Stock Chart
ELGX [NASD]
Endologix, Inc.
Index- P/E- EPS (ttm)-0.77 Insider Own2.00% Shs Outstand85.38M Perf Week-4.47%
Market Cap455.93M Forward P/E- EPS next Y-0.52 Insider Trans0.00% Shs Float81.78M Perf Month-15.77%
Income-64.50M PEG- EPS next Q-0.15 Inst Own99.10% Short Float7.29% Perf Quarter23.90%
Sales180.80M P/S2.52 EPS this Y58.50% Inst Trans0.00% Short Ratio11.72 Perf Half Y25.94%
Book/sh0.70 P/B7.63 EPS next Y9.70% ROA-17.30% Target Price5.65 Perf Year5.74%
Cash/sh- P/C- EPS next 5Y36.95% ROE-82.10% 52W Range3.75 - 6.72 Perf YTD-0.19%
Dividend- P/FCF- EPS past 5Y-5.80% ROI-14.80% 52W High-20.54% Beta0.28
Dividend %- Quick Ratio1.40 Sales past 5Y11.30% Gross Margin66.90% 52W Low42.40% ATR0.22
Employees675 Current Ratio2.10 Sales Q/Q-0.70% Oper. Margin-23.60% RSI (14)38.89 Volatility2.76% 4.02%
OptionableYes Debt/Eq3.87 EPS Q/Q8.10% Profit Margin-35.90% Rel Volume0.45 Prev Close5.39
ShortableYes LT Debt/Eq3.58 EarningsAug 01 AMC Payout- Avg Volume508.41K Price5.34
Recom2.80 SMA20-6.90% SMA50-4.58% SMA2008.39% Volume229,701 Change-0.93%
Jan-02-18Downgrade JP Morgan Neutral → Underweight
Dec-12-17Resumed Piper Jaffray Overweight
Nov-08-17Reiterated RBC Capital Mkts Sector Perform $5 → $4
May-18-17Downgrade Stifel Buy → Hold $10 → $5.50
Nov-17-16Downgrade Canaccord Genuity Buy → Hold $13.50 → $7.50
Nov-16-16Downgrade JP Morgan Overweight → Neutral
Sep-06-16Initiated Leerink Partners Mkt Perform
Aug-03-16Downgrade RBC Capital Mkts Outperform → Sector Perform $17 → $12
Jun-13-16Reiterated RBC Capital Mkts Outperform $15 → $17
May-10-16Reiterated RBC Capital Mkts Outperform $11 → $15
Apr-04-16Resumed JP Morgan Overweight
Feb-23-16Reiterated RBC Capital Mkts Outperform $15 → $11
Feb-02-16Reiterated Stifel Buy $17 → $15
Nov-17-15Reiterated RBC Capital Mkts Outperform $17 → $15
Oct-19-15Initiated RBC Capital Mkts Outperform $17
Aug-06-15Upgrade JP Morgan Neutral → Overweight $17
Aug-04-15Reiterated Stifel Buy $20 → $17
Apr-30-15Reiterated Oppenheimer Perform $15 → $17
Apr-06-15Reiterated Stifel Buy $17 → $20
Oct-01-14Reiterated Stifel Buy $17 → $15
Jul-16-18 04:01PM  Endologix, Inc. to Announce Second Quarter 2018 Financial Results on August 9, 2018 Business Wire
Jun-29-18 07:20AM  Free Technical Research on Valeritas Holdings and Three More Medical Supplies Equities ACCESSWIRE
Jun-28-18 08:10AM  Market Trends Toward New Normal in Endologix, Sanmina, First American Financial, Expeditors International of Washington, Liberty Broadband, and Nu Skin Enterprises Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
08:00AM  Endologix Reports Positive 1-Year Results from the Ovation® LUCY Study Business Wire
Jun-25-18 04:01PM  Endologix Appoints Jeffry Fecho as Chief Quality Officer Business Wire
Jun-07-18 11:06AM  What Is Endologix Incs (NASDAQ:ELGX) Share Price Doing? Simply Wall St.
May-29-18 07:00AM  Free Daily Technical Summary Reports on Endologix and Three Other Medical Supplies Stocks ACCESSWIRE
May-17-18 06:02PM  Edited Transcript of ELGX earnings conference call or presentation 2-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-15-18 08:25AM  Analysis: Positioning to Benefit within G-III Apparel Group, LTD, Diebold Nixdorf, Endologix, MACOM Technology Solutions, Halyard Health, and REV Group Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-02-18 07:17PM  Endologix: 1Q Earnings Snapshot Associated Press
04:15PM  Endologix Appoints John Onopchenko as Chief Executive Officer Business Wire
04:14PM  Endologix Reports First Quarter 2018 Financial Results Business Wire
Apr-25-18 10:00AM  Endovascular Aneurysm Sealing (EVAS) with Nellix System Associated with Higher Survival than Traditional Endovascular Aneurysm Repair (EVAR) in New Study Business Wire
Apr-10-18 08:15PM  Has Endologix Inc (NASDAQ:ELGX) Improved Earnings Growth In Recent Times? Simply Wall St.
Apr-03-18 04:01PM  Endologix, Inc. to Announce First Quarter 2018 Financial Results on May 2, 2018 Business Wire
Mar-19-18 04:01PM  Endologix Reports Positive Results from Global ENCORE Analysis with Polymer Endovascular Aneurysm Repair (EVAR) Using Ovation Abdominal Stent Graft Systems Business Wire
01:26PM  Will Endologix Incs (NASDAQ:ELGX) Earnings Grow In The Year Ahead? Simply Wall St.
Mar-05-18 08:00AM  Endologix, Inc. Announces Enrollment of the First Patient in EVAS2 IDE Clinical Study of the Nellix® EndoVascular Aneurysm Sealing System Business Wire
07:50AM  Free Research Report as Haemonetics Revenues Grew 2.7% and Adjusted EPS Surged 44% ACCESSWIRE
Feb-28-18 02:51PM  What You Must Know About Endologix Incs (NASDAQ:ELGX) Financial Strength Simply Wall St.
Feb-22-18 12:10PM  Edited Transcript of ELGX earnings conference call or presentation 21-Feb-18 9:30pm GMT Thomson Reuters StreetEvents -7.65%
Feb-21-18 05:09PM  Endologix reports 4Q loss Associated Press
04:01PM  John McDermott Steps Down as Chief Executive Officer of Endologix, Inc. Business Wire
04:00PM  Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results Business Wire
12:00PM  Endologix, Inc. to Host Earnings Call ACCESSWIRE
10:50AM  Endologix Q4 Earnings Preview Benzinga
Feb-12-18 08:15AM  Detailed Research: Economic Perspectives on Haemonetics, Endologix, NRG Yield, Cirrus Logic, Macquarie Infrastructure, and Shake Shack What Drives Growth in Today's Competitive Landscape GlobeNewswire
Feb-05-18 08:00AM  Endologix, Inc. Completes Patient Enrollment in the ELEVATE IDE Clinical Study Business Wire
Jan-30-18 04:01PM  Endologix, Inc. to Present at the Leerink Partners 7th Annual Global Healthcare Conference Business Wire
Jan-29-18 08:00AM  Endologix Appoints Greg Morrow as Chief Marketing Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Jan-25-18 04:01PM  Endologix, Inc. to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on February 21, 2018 Business Wire
Jan-19-18 12:25PM  At $4.27, Is It Time To Buy Endologix Inc (NASDAQ:ELGX)? Simply Wall St.
Jan-04-18 02:10PM  Does Endologix Incs (NASDAQ:ELGX) Earnings Growth Make It An Outperformer? Simply Wall St.
Jan-02-18 03:45PM  JPMorgan Diagnoses The MedTech Space: Stock Picks And Pans Benzinga
Jan-01-18 07:12AM  Endologix, Inc. breached its 50 day moving average in a Bullish Manner : ELGX-US : January 1, 2018 Capital Cube
Dec-29-17 10:50PM  ENDOLOGIX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Endologix, Inc. - ELGX Business Wire
Dec-19-17 04:01PM  Endologix, Inc. to Present at the J.P. Morgan Healthcare Conference Business Wire
08:15AM  Factors of Influence in 2018, Key Indicators and Opportunity within Endologix, Haemonetics, Prudential Financial, AdvanSix, PolyOne, and Rexford Industrial Realty New Research Emphasizes Economic Growth GlobeNewswire
Dec-15-17 10:50PM  ENDOLOGIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Endologix, Inc. - ELGX PR Newswire
08:00AM  Endologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : December 15, 2017 Capital Cube
Dec-07-17 01:38PM  ETFs with exposure to Endologix, Inc. : December 7, 2017 Capital Cube
Dec-05-17 09:22AM  Endologix, Inc. :ELGX-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017 Capital Cube
Dec-01-17 10:50PM  ENDOLOGIX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Endologix, Inc. - ELGX Business Wire
Nov-27-17 09:06PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of Endologix, Inc. (ELGX) on Behalf of Shareholders Business Wire
Nov-14-17 04:01PM  Endologix, Inc. to Present at the Piper Jaffray 29th Annual Healthcare Conference Business Wire
Nov-11-17 08:18PM  Edited Transcript of ELGX earnings conference call or presentation 7-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-10-17 01:11PM  Endologix, Inc. Value Analysis (NASDAQ:ELGX) : November 10, 2017 Capital Cube
Nov-09-17 07:53AM  Endologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : November 9, 2017 Capital Cube
Nov-07-17 04:51PM  Endologix reports 3Q loss Associated Press -7.84%
04:01PM  Endologix Reports Third Quarter 2017 Financial Results Business Wire
10:10AM  Endologix, Inc. to Host Earnings Call ACCESSWIRE
06:53AM  NasdaqGS Healthcare Industry: A Deep Dive Into Endologix Inc (ELGX) Simply Wall St.
Nov-01-17 04:01PM  Endologix Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire +5.09%
Oct-30-17 04:51PM  Is Endologix Inc (ELGX) A Financially Sound Company? Simply Wall St.
Oct-27-17 10:52AM  ETFs with exposure to Endologix, Inc. : October 27, 2017 Capital Cube
Oct-26-17 04:01PM  Endologix, Inc. to Present at the Stifel 2017 Healthcare Conference Business Wire
Oct-19-17 08:00AM  Endologix Appoints John Onopchenko as Chief Operating Officer Business Wire
Oct-16-17 03:37PM  What Does Endologix Incs (ELGX) Share Price Indicate? Simply Wall St.
Oct-10-17 04:01PM  Endologix, Inc. to Announce Third Quarter 2017 Financial Results on November 7, 2017 Business Wire
Oct-06-17 08:00AM  Endologix Receives IDE Approval for the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix® EndoVascular Aneurysm Sealing System Business Wire
Oct-03-17 11:11AM  ETFs with exposure to Endologix, Inc. : October 3, 2017 Capital Cube +20.62%
Sep-30-17 04:02PM  What Are The Drivers Of Endologix Incs (ELGX) Risks? Simply Wall St.
Sep-27-17 08:00AM  Endologix, FDA Delays Nellix EVAS in May, Guidance and Pipeline Review ACCESSWIRE
Sep-22-17 11:10AM  ETFs with exposure to Endologix, Inc. : September 22, 2017 Capital Cube
Sep-21-17 12:57PM  Endologix, Inc. :ELGX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017 Capital Cube
08:00AM  Endologix Announces CE Mark Approval for the Nellix® EndoVascular Aneurysm Sealing System with the Refined Indications for Use Business Wire
Sep-13-17 08:31PM  Is There Now An Opportunity In Endologix Inc (ELGX)? Simply Wall St.
Sep-11-17 08:00AM  Endologix Announces Collaboration Agreements with Japan Lifeline for the Development and Commercialization of Thoracic Endovascular Systems in Japan Business Wire
Aug-17-17 08:00AM  Endologix Announces Positive Clinical Results from the LEOPARD Clinical Study Business Wire
Aug-15-17 05:44PM  Endologix, Inc. Value Analysis (NASDAQ:ELGX) : August 15, 2017 Capital Cube
Aug-12-17 08:30PM  Edited Transcript of ELGX earnings conference call or presentation 2-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-07-17 04:21PM  3 Stocks Hitting 52-Week Lows: Time to Go Bargain Shopping? Motley Fool
Aug-02-17 10:59PM  Endologix reports 2Q loss Associated Press
04:01PM  Endologix Reports Second Quarter 2017 Financial Results Business Wire
10:20AM  Investor Network: Endologix, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-17 09:15AM  Endologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : August 1, 2017 Capital Cube
Jul-12-17 04:01PM  Endologix, Inc. to Announce Second Quarter 2017 Financial Results on August 2, 2017 Business Wire
Jul-10-17 04:01PM  Endologix, Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference Business Wire
Jul-03-17 02:55PM  Lifshitz & Miller LLP Announces Investigation of Aaron's, Inc., Axiom Holdings, Inc., Booz Allen Hamilton Holding Corporation, CenturyLink, Inc., Endologix, Inc., Sky Solar Holdings, Ltd. and Rightside Group, Ltd. PR Newswire
Jun-13-17 08:33AM  ENDOLOGIX ALERT: J&W Investigates Endologix, Inc.; Long Term Investors Encouraged to Contact the Firm PR Newswire
Jun-12-17 12:47PM  Robbins Arroyo LLP: Endologix, Inc. (ELGX) Misled Shareholders According to a Recently Filed Class Action Business Wire
Jun-03-17 12:00PM  Endologix Presents Positive Two-Year Clinical Data from the Nellix® EVAS FORWARD IDE Trial Business Wire
Jun-01-17 04:19AM  Endologix Reports Positive Clinical Data from the Ovation LUCY Study with 1.3% Major Adverse Event Benzinga
May-31-17 09:30PM  Endologix Reports Positive Clinical Data from the Ovation LUCY Study Business Wire
May-26-17 01:06PM  ETFs with exposure to Endologix, Inc. : May 26, 2017 Capital Cube
12:09PM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Endologix, Inc. ELGX Business Wire
May-19-17 08:00AM  Today's Research Reports on Stocks to Watch: GlycoMimetics and Endologix Accesswire
May-18-17 12:30PM  Why Endologix Shares Are Hitting a Multiyear Low 24/7 Wall St. -36.70%
11:20AM  Why Endologix, Inc. Is Getting Crushed Today Motley Fool
May-17-17 04:45PM  Endologix Provides an Update on the Nellix® Endovascular Aneurysm Sealing System U.S. Regulatory Status Business Wire
May-16-17 08:16AM  Endologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : May 16, 2017 Capital Cube
May-11-17 04:35PM  ETFs with exposure to Endologix, Inc. : May 11, 2017 Capital Cube
May-10-17 08:46AM  Edited Transcript of ELGX earnings conference call or presentation 4-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-09-17 11:44AM  Endologix, Inc. :ELGX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 Capital Cube
May-04-17 05:14PM  Endologix reports 1Q loss Associated Press
04:01PM  Endologix Reports First Quarter 2017 Financial Results Business Wire
May-02-17 08:37AM  Implied Volatility Surging for Endologix (ELGX) Stock Options Zacks
May-01-17 04:38PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Endologix, Inc. - ELGX PR Newswire
Apr-24-17 04:01PM  Endologix, Inc. to Host an Investor Conference Call to Discuss its Nellix® Endovascular Aneurysm Sealing System Presentation at the Society of Vascular Surgery Annual Meeting on June 3, 2017 Business Wire
03:19PM  Endologix, Inc. Value Analysis (NASDAQ:ELGX) : April 24, 2017 Capital Cube
Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. It offers minimally-invasive endovascular repair (EVAR) products, including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the ovation abdominal stent graft system. The company also provides endovascular sealing (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, it offers proximal aortic extensions and limb extensions which allows physicians to customize the implant to fit the patient's anatomy; and accessories to facilitate the delivery of its EVAR and EVAS products, including compatible guidewires, inflation devices, and snares. The company offers its EVAR products under Ovation, Powerlink System, IntuiTrak, AFX, VELA Proximal Endograft brand names; and EVAS products under the Nellix EVAS system brand name. It sells its products through direct sales force, network of agents, and independent distributors or agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chavez Christopher G.DirectorMay 29Sale5.671691378,346May 30 07:39 PM
McDermott John DDirectorMay 10Option Exercise2.67177,065472,7641,020,212May 14 06:18 PM
McDermott John DChief Executive OfficerMar 27Option Exercise2.67250,000667,500838,659Mar 28 05:13 PM